SEC Filings

8-K
ARRAY BIOPHARMA INC filed this Form 8-K on 09/15/2017
Entire Document
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:

September 15, 2017

Array BioPharma Inc.

 

 

 

 

 

 

 

 

 

 

By:

/s/ Jason Haddock

 

 

 

Jason Haddock

 

 

 

Chief Financial Officer

 

4